Journal of International Oncology››2021,Vol. 48››Issue (2): 92-95.doi:10.3760/cma.j.cn371439-20200923-00017
• Reviews •Previous ArticlesNext Articles
He Zhefeng, Pei Tiemin, Meng Qinghui(
)
Received:2020-09-23Revised:2020-10-07Online:2021-02-08Published:2021-03-11Contact:Meng Qinghui E-mail:hui-90@163.comSupported by:
He Zhefeng, Pei Tiemin, Meng Qinghui. IGF2BP1 and cancer[J]. Journal of International Oncology, 2021, 48(2): 92-95.
| [1] | Bell JL, Wächter K, Mühleck B, et al. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?[J]. Cell Mol Life Sci, 2013,70(15):2657-2675. DOI: 10.1007/s00018-012-1186-z. doi:10.1007/s00018-012-1186-z |
| [2] | Carmel MS, Kahane N, Oberman F, et al. A novel role for VICKZ proteins in maintaining epithelial integrity during embryogenesis[J]. PLoS One, 2015,10(8):e0136408. DOI: 10.1371/journal.pone.0136408. doi:10.1371/journal.pone.0136408 |
| [3] | Huang H, Weng H, Sun W, et al. Recognition of RNA N6-methyla-denosine by IGF2BP proteins enhances mRNA stability and translation[J]. Nat Cell Biol, 2018,20(3):285-295. DOI: 10.1038/s41556-018-0045-z. doi:10.1038/s41556-018-0045-z |
| [4] | Biswas J, Nunez L, Das S, et al. Zipcode binding protein 1 (ZBP1; IGF2BP1): a model for sequence-specific RNA regulation[J]. Cold Spring Harb Symp Quant Biol, 2019,84:1-10. DOI: 10.1101/sqb.2019.84.039396. doi:10.1101/sqb.2019.84.039396pmid:32086331 |
| [5] | Gutschner T, Hämmerle M, Pazaitis N, et al. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma[J]. Hepatology, 2014,59(5):1900-1911. DOI: 10.1002/hep.26997. doi:10.1002/hep.26997 |
| [6] | Yuan P, Meng L, Wang N. SOX12 upregulation is associated with metastasis of hepatocellular carcinoma and increases CDK4 and IGF2BP1 expression[J]. Eur Rev Med Pharmacol Sci, 2017,21(17):3821-3826. pmid:28975985 |
| [7] | Peng L, Yuan XQ, Zhang CY, et al. The emergence of long non-coding RNAs in hepatocellular carcinoma: an update[J]. J Cancer, 2018,9(14):2549-2558. DOI: 10.7150/jca.24560. doi:10.7150/jca.24560pmid:30026854 |
| [8] | Xu Y, Zheng Y, Liu H, et al. Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transduction[J]. Int J Oncol, 2017,51(3):791-800. DOI: 10.3892/ijo.2017.4066. doi:10.3892/ijo.2017.4066pmid:28677801 |
| [9] | Zhou X, Zhang CZ, Lu SX, et al. miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma[J]. Oncogene, 2016,35(38):5078. DOI: 10.1038/onc.2016.61. pmid:27477694 |
| [10] | Jiang T, Li M, Li Q, et al. MicroRNA-98-5p inhibits cell proliferation and induces cell apoptosis in hepatocellular carcinoma via targeting IGF2BP1[J]. Oncol Res, 2017,25(7):1117-1127. DOI: 10.3727/096504016X14821952695683. doi:10.3727/096504016X14821952695683pmid:28244848 |
| [11] | Fawzy IO, Hamza MT, Hosny KA, et al. miR-1275: a single microRNA that targets the three IGF2-mRNA-binding proteins hindering tumor growth in hepatocellular carcinoma[J]. FEBS Lett, 2015,589(17):2257-2265. DOI: 10.1016/j.febslet.2015.06.038. doi:10.1016/j.febslet.2015.06.038pmid:26160756 |
| [12] | Rebucci M, Sermeus A, Leonard E, et al. miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1[J]. Mol Cancer, 2015,14:79. DOI: 10.1186/s12943-015-0349-6. pmid:25889892 |
| [1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325. |
| [2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
| [3] | Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343. |
| [4] | Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349. |
| [5] | Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353. |
| [6] | Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358. |
| [7] | Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363. |
| [8] | Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369. |
| [9] | Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375. |
| [10] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
| [11] | Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273. |
| [12] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279. |
| [13] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285. |
| [14] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291. |
| [15] | Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
